Holen Sie sich die Stockscreener-App
6.93
4.55%
-0.33
Handel nachbörslich:
6.91
-0.02
-0.29%
Schlusskurs vom Vortag:
$7.26
Offen:
$7.445
24-Stunden-Volumen:
39,866
Relative Volume:
0.32
Marktkapitalisierung:
$26.63M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.14%
1M Leistung:
-34.81%
6M Leistung:
-17.74%
1J Leistung:
+268.62%
1-Tages-Spanne:
$6.91
$7.4611
1-Wochen-Bereich:
$6.855
$7.65
52-Wochen-Spanne:
$1.445
$19.12
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Firmenname
Quantum Biopharma Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie QNTM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
6.93 | 27.90M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Quantum Biopharma Ltd Aktie (QNTM) Neueste Nachrichten
Quantum BioPharma closes private placement, enhances governance - MSN
QUANTUM BIOPHARMA DEADLINE FOR LEADERSHIP is February 23, 2026 in a Securities Fraud LawsuitContact Kaplan Fox & Kilsheimer LLP - NewMediaWire
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares - The Ithaca Journal
Deadline to Lead in Securities Class Action Against Quantum Biopharma Ltd. (QNTM) is February 23, 2026Contact Kaplan Fox - FinancialContent
How supply chain issues affect Quantum BioPharma Ltd. stockJuly 2025 Big Picture & AI Forecasted Stock Moves - ulpravda.ru
Will Quantum BioPharma Ltd. stock attract ESG investorsJuly 2025 Momentum & Stepwise Trade Signal Guides - ulpravda.ru
How strong is Quantum BioPharma Ltd. stock balance sheetTreasury Yields & Real-Time Volume Trigger Notifications - ulpravda.ru
Will Quantum BioPharma Ltd. (0K91) stock enhance shareholder value2025 Price Momentum & Free Expert Verified Stock Movement Alerts - ulpravda.ru
QNTM CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Quantum Biopharma Ltd. (QNTM) and Lead Plaintiff Deadline on February 23, 2026 - NewMediaWire
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Why Quantum BioPharma Ltd. (0K91) stock signals breakout potentialTreasury Yields & Consistent Growth Stock Picks - ulpravda.ru
How Quantum BioPharma Ltd. stock reacts to global recession fearsRetail Trading Trends & Budget Friendly Trading Ideas - ulpravda.ru
Is Quantum BioPharma Ltd. (0K91) stock dividend growth reliableStock Watchlist Updates & Big Returns Small Capital - ulpravda.ru
QNTM DEADLINE: Investors of Quantum Biopharma Ltd. (QNTM) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on February 23, 2026 - NewMediaWire
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Kaplan Fox Alerts Quantum Biopharma Ltd. (QNTM) Investors to a Se - The National Law Review
Kaplan Fox Alerts Quantum Biopharma Ltd. (QNTM) Investors to a Securities Class Action LawsuitDeadline is February 23, 2026 - FinancialContent
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
QNTM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
QUANTUM BIOPHARMA Investors are Encouraged to Contact Kaplan Fox Regarding the Securities Class Action Lawsuit - NewMediaWire
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma - GlobeNewswire
Kaplan Fox Reminds Quantum Biopharma Ltd. (QNTM) Investors of a Securities Class Action Lawsuit - The Globe and Mail
Kaplan Fox Encourages Investors of Quantum Biopharma Ltd. (QNTM) to Contact the Firm Regarding the Securities Class Action Lawsuit - NewMediaWire
Dow Theory LettersKaplan Fox Encourages Investors of Quantum Biopharma Ltd. (QNTM) to Contact the Firm Regarding the Securities Class Action Lawsuit - FinancialContent
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Kaplan Fox Alerts Investors of Quantum Biopharma Ltd. (QNTM) to a Securities Class Action Lawsuit - The National Law Review
QNTM STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Kaplan Fox Alerts Investors to Securities Class Action on Behalf of Quantum Biopharma Ltd. (QNTM) Shareholders - NewMediaWire
Cannabis Stocks To Follow TodayDecember 11th - MarketBeat
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Celly Nutrition targets IPO with $10 million capital raise - MSN
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Quantum BioPharma Ltd Stock Analysis and ForecastVolatility Adjusted Trading & Small Budget Capital Gains - earlytimes.in
Quantum BioPharma completes key toxicity studies for Lucid-MS, paving way for Phase 2 MS trial - Indian Pharma Post
Cannabis Stocks To Follow NowDecember 1st - MarketBeat
QNTM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm - The Malaysian Reserve
QNTM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Quantum BioPharma completes oral dosing in key MS drug studies By Investing.com - Investing.com Australia
Quantum BioPharma completes 180-day toxicity dosing for lead MS drug Lucid-MS - MSN
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Completes 180-Day Toxicity Studies for Lucid-MS - FinancialContent
Grant & Eisenhofer Files Securities Class Action Lawsuit Against Canadian Imperial Bank of Commerce and Royal Bank of Canada on behalf of investors in Quantum Biopharma Ltd. Securities - FinancialContent
Finanzdaten der Quantum Biopharma Ltd-Aktie (QNTM)
Es liegen keine Finanzdaten für Quantum Biopharma Ltd (QNTM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):